785688002: Carbidopa anhydrous (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)\Carbidopa anhydrous
\Substance categorized by disposition\Receptor agonist\Dopamine receptor agonist\Dihydroxyphenylalanine\Carbidopa anhydrous

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Antiparkinsonian agent (substance)\...

\Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)\Carbidopa anhydrous

\Dihydroxyphenylalanine\Carbidopa anhydrous

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Carbidopa anhydrous

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Carbidopa anhydrous

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3767988015 Carbidopa anhydrous en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3767989011 Carbidopa anhydrous (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carbidopa anhydrous	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Dihydroxyphenylalanine decarboxylase inhibitor (disposition)	true	Inferred relationship	Some
Carbidopa anhydrous	Is a	Dihydroxyphenylalanine	true	Inferred relationship	Some
Carbidopa anhydrous	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Carbidopa	true	Inferred relationship	Some
Carbidopa anhydrous	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Dopamine receptor agonist (disposition)	true	Inferred relationship	Some
Carbidopa anhydrous	Is a	Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa anhydrous	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa anhydrous	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa anhydrous	Inferred relationship	Some	3
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa anhydrous	Inferred relationship	Some	3
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa anhydrous	Inferred relationship	Some	2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa anhydrous	Inferred relationship	Some	1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa anhydrous	Inferred relationship	Some	2
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa anhydrous	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa anhydrous	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa anhydrous	Inferred relationship	Some	2
Product containing precisely carbidopa anhydrous (as carbidopa) 43.75 milligram and entacapone 200 milligram and levodopa 175 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa anhydrous	Inferred relationship	Some	3
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa anhydrous	Inferred relationship	Some	3

This concept is not in any reference sets